Opelousas General Health System — Opelousas, Louisiana

Opelousas General Health System is a clinical research site located in Opelousas, Louisiana, United States 70570.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Opelousas General Health System has participated in 2 clinical trials.

Therapeutic areas: Peripheral Vascular Disease, Cardiovascular Disease..

Sponsors: Abbott Medical Devices, Arstasis, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Opelousas

Browse all research sites in Louisiana · View every site in Opelousas

• Opelousas General Hospital
• Opelousas General Hospital Wound Center
• Novartis Investigative Site
• Research Site
• CV Ins of the South
• Cardiovascular Institute of the South
• Novartis Investigator Site
• FMC Opelousas
• Acadiana Medicine Clinic
• Forest Investigative Site 1812
• Opelousas General
• Furiex Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Opelousas General Health System?

Opelousas General Health System has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Opelousas General Health System conducted?

Opelousas General Health System has 2 clinical trials on record. Their work covers Peripheral Vascular Disease, Cardiovascular Disease..

Is Opelousas General Health System accredited by Crixeo Clinical Trials?

Opelousas General Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Opelousas General Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.